Company: SMNR
Filing Date: 2025-12-03
Form Type: 8-K
Source: 0001193125-25-306757
Chunk: 0

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-12-03
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

Semnur Pharmaceuticals, Inc. (the “ Company”) is filing this Current Report on Form8-Kfor the purpose of updating the description of the Company’s securities, giving effect to amendments to the Company’s Certificate of Incorporation and Bylaws since the end of its fiscal year ended December 31, 2024.

The Description of Securities attached hereto as Exhibit 4.1 modifies and supersedes any prior description of securities of the Company in any registration statement or report filed with the Securities and Exchange Commission (the “ SEC”) and is available for incorporation by reference into certain of the Company’s filings with the SEC pursuant to the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the rules and forms promulgated thereunder.